RE:RE:RE:RE:RE:Pssst, an "earn-out" is due this week...Listen DumDum.The earn out due Oct 1 ( with half of it deferrable till Feb 2017) is £144M. Now, when I went to school £144M multiplied by 1.3 exchange rate = €187.2 M . And as you copied the release in June, the 4 drugs they bought cost CXR £21M with a £7 M earn out due 2017.
So stop creating numbers out of thin air. So just to recap for the challenged dum dums CXR has an earnout of £144M due for the AMCo purchase and £7M earnout due for the 4 drugs purchased in 2017. £144 + £7 = £151M of which only £72M is due 01 OCT. Now that the math took in school.
By the looks of things you dropped out of school before you learnt your basic math.
quote=TheGreatKazoo]
TheGreatKazoo rejects all deals not driven by "advanced science" and the truth. Both in short supply here....
I will tell all dum-dums that the additional $72M on top of the $222M does in fact add up to $294M, let's round that up to $300M I know, it wasn't fair, you needed to find your calculators dum-dums.
The additional $72M is due to Cinven this week. Surprise!
Advanced Science reveals the payment is due because these are UK based drugs and who is based in the UK to "introduce" these wonderful deals filled with "goodwill" to a willing company who gets others (shareholders and debtholders) to pay for them? Cinven! of course ladies and gentlemen! Thompson's good friends, I'm sure?
Drugs, for those who can't use Advanced Science are:
- Trazodone Hydrochloride from Focus Pharmaceuticals www.focuspharmaceuticals.co.uk
- Sytron® from Archimedes Pharma of the UK as well
The "third party" is in fact "secret" so why talk about it? They needed to jack up the prices first! That's the model, jack up the price, drive up short term FCF and Boom! Write off the bad assets and keep the debt to sink the ship!
But we know it's UK based so PAY UP shareholders! Please! Cinven and Thompson want to dump their last remaining shares at the highest price before this collapses!!
Thompson no longer has shares in his own name, that offshore "numbered company" does and its been selling on pre-determined triggers not disclosed it seems?
AHHHHH Why disclose anyway? it's tedious, leaves papertrails etc. That's why Concordia is getting ready to go private. No disclosure requirements there, no pesky shareholders that discuss "bumps under the carpets" in these public ex-mining anonymous forums, no activist shareholders (the deal with Cinven make sure of that).
So they are just getting ready for that. Why come down hard on them??? Pop some pills, the pain might go away and share price might go higher in you head and make you feel good.
...................
Concordia Healthcare Completes Acquisition of Four Generic Products OAKVILLE, ON – June 1, 2016 – Concordia Healthcare Corp. (“Concordia” or the “Company”) (NASDAQ: CXRX) (TSX: CXR), an international pharmaceutical company focused on legacy pharmaceutical products and orphan drugs, announced today that it has completed the acquisition of the global rights to four generic products, as previously announced on May 13, 2016. These products include Sodium Feredetate oral solution for the treatment of anemia, Trazadone oral solution for the treatment of depression, as well as two additional pipeline products. The Company paid £21 million for the acquisition with cash on hand. An additional £7 million in earn-out payments will be payable in the first quarter of 2017 if certain performance and supply targets are achieved. “We are always looking for quality assets at compelling multiples, and we believe that this acquisition at approximately 2.6 times pro forma 2016 revenue is an exceptional opportunity for us,” said Mark Thompson, Founder, Chairman and Chief Executive Officer of Concordia.[/quote]